Product image of Labella (Levonorgestrel) supplied by GNH India

Labella

Active Ingredient:
Levonorgestrel
Origin:
EU

Labella (Levonorgestrel)

Levonorgestrel, the active ingredient in Labella, is a progestin presented as an oral tablet for oral use. It is employed to prevent pregnancy, including emergency contraception after unprotected intercourse.
GNH India supplies Labella as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Uab Exeltis Baltics

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Levonorgestrel acts on the hormonal pathways that regulate ovulation and implantation, making it suitable for contraception.

  • Emergency contraception: prevents pregnancy when taken shortly after unprotected sex.
  • Hormonal contraception: used as a regular method to inhibit ovulation and alter the endometrial lining.
  • Ovulation inhibition: suppresses the release of an egg when administered before the luteinizing hormone surge.

How It Works

  • Levonorgestrel binds to progesterone receptors in the hypothalamus and pituitary, suppressing the luteinizing hormone surge and thereby inhibiting ovulation. It also induces changes in cervical mucus, reduces tubal motility, and alters the endometrial lining, creating an environment unfavorable for fertilization and implantation.

Side Effects

Levonorgestrel may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Headache: occasional tension‑type headaches.
  • Breast tenderness: temporary discomfort in breast tissue.
  • Menstrual changes: spotting or altered cycle timing.
  • Dizziness: brief episodes of light‑headedness.

Serious or Rare Side Effects

  • Thromboembolic events: rare blood clot formation.
  • Severe allergic reaction: hives, swelling, or anaphylaxis.
  • Liver dysfunction: abnormal liver enzyme levels.
  • Pregnancy complications: if taken during an unrecognized early pregnancy.
  • Persistent abdominal pain: may indicate underlying pathology.

Precautions & Warnings

Levonorgestrel should be used with awareness of specific safety considerations.

  • Contraindication: known hypersensitivity to levonorgestrel or any tablet excipients.
  • Pregnancy: not indicated for ongoing pregnancy; seek medical advice if pregnancy is suspected.
  • Hepatic impairment: use with caution in patients with liver disease.
  • Thromboembolic history: avoid in individuals with a history of clotting disorders.
  • Drug interactions: review concomitant medications (see interactions section).
  • Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Levonorgestrel can interact with several medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

  • Rifampin: induces metabolism, reducing contraceptive effectiveness.
  • Anticonvulsants (e.g., carbamazepine, phenytoin): increase clearance, compromising efficacy.
  • St. John’s wort: herbal inducer that may lower drug levels.
  • HIV protease inhibitors (e.g., ritonavir): may alter hormonal activity.
  • Certain antibiotics (e.g., griseofulvin): can reduce contraceptive reliability.

Moderate Interactions (Monitor Closely)

  • Antifungals (ketoconazole, itraconazole): may increase hormone levels, requiring monitoring.
  • Antibiotics (tetracycline, metronidazole): potential modest reduction in effectiveness.
  • Hormonal therapies (combined oral contraceptives): may require dosage adjustments.

Frequently Asked Questions

Labella contains levonorgestrel, a progestin used primarily for emergency contraception and as a hormonal method to prevent pregnancy. It works by inhibiting ovulation and altering the uterine environment to reduce the chance of fertilization and implantation.

Levonorgestrel binds to progesterone receptors in the brain, suppressing the luteinizing hormone surge that triggers ovulation. It also thickens cervical mucus, slows tubal motility, and modifies the endometrial lining, creating conditions that are unfavorable for sperm passage and embryo implantation.

The specific dose of Labella is determined by the prescribing healthcare professional based on the indication and patient characteristics. Dosage instructions are provided on the product label and should be followed exactly as directed by a qualified prescriber.

Labella is intended to prevent pregnancy and is not used during an established pregnancy. Women who become pregnant while taking levonorgestrel should contact their healthcare provider. Limited data are available for breastfeeding; generally, short‑term use is considered compatible, but a clinician should evaluate individual risk.

To place an order, submit an enquiry on the Labella product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Labella’s active ingredient, levonorgestrel, is a well‑studied progestin offering comparable efficacy to other levonorgestrel‑based emergency pills. Alternatives such as ulipristal acetate may have a longer window of effectiveness, while copper IUD insertion provides the highest efficacy, but Labella remains a convenient oral option for most users.

Labella tablets should be stored at room temperature, below 25 °C, in their original blister pack or container. Protect them from moisture, excessive heat, and direct sunlight to maintain stability and potency throughout the shelf life.

Labella is taken orally, usually as a single tablet taken as soon as possible after unprotected intercourse, ideally within 72 hours. The tablet should be swallowed whole with water and not chewed or broken.

Serious risks, though rare, include thromboembolic events, severe allergic reactions such as anaphylaxis, and liver dysfunction. Users should seek immediate medical attention if they experience symptoms like unexplained swelling, severe abdominal pain, jaundice, or signs of a blood clot.

Labella should not be used by individuals with a known hypersensitivity to levonorgestrel or any tablet excipients, those who are currently pregnant, or persons with a history of thromboembolic disorders, severe liver disease, or uncontrolled hypertension without prior medical evaluation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.